148 related articles for article (PubMed ID: 30677483)
1. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation.
Sun J; Yang D; Cui SH; Zhang HT; Fu Y; Wang JC; Zhang Q
Int J Pharm; 2019 Mar; 559():48-57. PubMed ID: 30677483
[TBL] [Abstract][Full Text] [Related]
2. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy.
Wang J; Li Q; Li X; Yuan W; Huang S; Cai S; Xu J
Eur J Pharmacol; 2017 Nov; 815():166-172. PubMed ID: 28919026
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
Deng LJ; Wang LH; Peng CK; Li YB; Huang MH; Chen MF; Lei XP; Qi M; Cen Y; Ye WC; Zhang DM; Chen WM
J Med Chem; 2017 Jul; 60(13):5320-5333. PubMed ID: 28595013
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.
Chai XP; Sun GL; Fang YF; Hu LH; Liu X; Zhang XW
Acta Pharmacol Sin; 2018 Mar; 39(3):415-424. PubMed ID: 29119969
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.
Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S
J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542
[TBL] [Abstract][Full Text] [Related]
6. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
Guo B; Wei J; Wang J; Sun Y; Yuan J; Zhong Z; Meng F
Acta Biomater; 2022 Jun; 145():200-209. PubMed ID: 35430336
[TBL] [Abstract][Full Text] [Related]
7. Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing.
Li Q; Cao J; Wang Q; Zhang J; Zhu S; Guo Z; Zhu WH
J Mater Chem B; 2019 Mar; 7(9):1503-1509. PubMed ID: 32255021
[TBL] [Abstract][Full Text] [Related]
8. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anticancer activity of gemcitabine coupling with conjugated linoleic acid against human breast cancer in vitro and in vivo.
Tao XM; Wang JC; Wang JB; Feng Q; Gao SY; Zhang LR; Zhang Q
Eur J Pharm Biopharm; 2012 Oct; 82(2):401-9. PubMed ID: 22728546
[TBL] [Abstract][Full Text] [Related]
10. Stereocomplex Prodrugs of Oligo(lactic acid)
Tam YT; Huang C; Poellmann M; Kwon GS
ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
[TBL] [Abstract][Full Text] [Related]
11. A biocompatible and cathepsin B sensitive nanoscale system of dendritic polyHPMA-gemcitabine prodrug enhances antitumor activity markedly.
Dai Y; Ma X; Zhang Y; Chen K; Tang JZ; Gong Q; Luo K
Biomater Sci; 2018 Nov; 6(11):2976-2986. PubMed ID: 30255871
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
[TBL] [Abstract][Full Text] [Related]
13. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
Li X; Chen M; Lu W; Tang J; Deng L; Wen Q; Huang M; Deng R; Ye G; Ye W; Zhang D
Cancer Lett; 2021 Apr; 503():32-42. PubMed ID: 33482262
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
[TBL] [Abstract][Full Text] [Related]
15. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
Tsume Y; Drelich AJ; Smith DE; Amidon GL
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
[TBL] [Abstract][Full Text] [Related]
16. An Amphiphilic PEGylated Peptide Dendron-Gemcitabine Prodrug-Based Nanoagent for Cancer Therapy.
Li N; Duan Z; Wang L; Guo C; Zhang H; Gu Z; Gong Q; Luo K
Macromol Rapid Commun; 2021 Jun; 42(12):e2100111. PubMed ID: 33871122
[TBL] [Abstract][Full Text] [Related]
17. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
18. Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma.
Wu L; Zhang F; Chen X; Wan J; Wang Y; Li T; Wang H
ACS Appl Mater Interfaces; 2020 Jan; 12(3):3327-3340. PubMed ID: 31872760
[TBL] [Abstract][Full Text] [Related]
19. Introduction of Z-GP scaffold into procarbazine reduces spermatoxicity and myelosuppression.
Wang R; Zhang C; Zheng C; Li H; Xie X; Jin Y; Liu Z; Chen H
Bioorg Chem; 2019 Mar; 83():461-467. PubMed ID: 30448724
[TBL] [Abstract][Full Text] [Related]
20. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy.
Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y
J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]